Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Osteoclastic acidification pathways during bone resorption.

A-V Rousselle1, D Heymann

  • 1Labaoratoire de Physiopathologie de la Résorption Osseuse, Faculté de Médecine, Nantes, France.

Bone
|April 6, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Circulating Tumor Cells: The Importance of Single Cell Analysis.

Advances in experimental medicine and biology·2018
Same author

3D curved multiplanar cone beam CT reconstruction for intracochlear position assessment of straight electrodes array. A temporal bone and clinical study.

Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale·2016
Same author

[Excimer laser-assisted lamellar endothelial keratoplasty (ExALEK): Technique and results].

Journal francais d'ophtalmologie·2016
Same author

Bone Like Arterial Calcification in Femoral Atherosclerotic Lesions: Prevalence and Role of Osteoprotegerin and Pericytes.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2015
Same author

Inhibition of osteolysis and increase of bone formation after local administration of siRNA-targeting RANK in a polyethylene particle-induced osteolysis model.

Acta biomaterialia·2014
Same author

Joint bleeding in factor VIII deficient mice causes an acute loss of trabecular bone and calcification of joint soft tissues which is prevented with aggressive factor replacement.

Haemophilia : the official journal of the World Federation of Hemophilia·2014

Osteoclasts use ion transport mechanisms, including vacuolar H+-adenosine triphosphatase (ATPase) and carbonic anhydrase II (CAII), to resorb bone. Understanding these processes offers potential therapeutic targets for metabolic bone diseases.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Physiology

Background:

  • Osteoclasts resorb bone by secreting protons to solubilize minerals and digest the organic matrix.
  • Acidification of the osteoclast-bone interface is crucial for bone resorption.
  • Ion transport mechanisms play a vital role in both bone resorption and osteoclast pH regulation.

Purpose of the Study:

  • To characterize the ion transport mechanisms involved in bone resorption.
  • To define the biochemical pathways underlying bone mineral dissolution.
  • To identify potential pharmacological targets for metabolic bone diseases.

Main Methods:

  • Summarization of existing research on ion transport in osteoclasts.
  • Characterization of vacuolar H+-adenosine triphosphatase (ATPase) and its role in acidification.

Related Experiment Videos

  • Analysis of carbonic anhydrase II (CAII) function in proton and bicarbonate production.
  • Investigation of HCO3-/Cl- exchanger, Na+/H+ antiporter, and K+ channels in pH homeostasis.

    • Main Results:

    • Vacuolar H+-ATPase coupled with Cl- conductance is the primary mechanism for extracellular acidification.
    • Carbonic anhydrase II (CAII) supplies protons for H+-ATPase and bicarbonate for the exchanger.
    • The HCO3-/Cl- exchanger and CAII are key for maintaining intracellular pH.
    • Other transporters like Na+/H+ antiporter and K+ channels contribute to pH regulation and recovery.

    Conclusions:

    • Ion transport systems are critical for both bone resorption and maintaining intracellular pH balance in osteoclasts.
    • Specific transporters and their associated biochemical pathways represent potential targets for pharmacological intervention.
    • Targeting these mechanisms could lead to new treatments for metabolic bone diseases.